{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:21:59Z","timestamp":1790868119236,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007924","name":"University of Louisville","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.nano.2022.102572","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T18:49:44Z","timestamp":1654368584000},"page":"102572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts"],"prefix":"10.1016","volume":"44","author":[{"given":"Anu","family":"Puri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"O'Reilly Beringhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camryn","family":"Isemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zakrevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Whittenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Dillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"de Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Nantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nano.2022.102572_bb0005","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2022.102572_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","article-title":"Liposomal siRNA nanocarriers for cancer therapy","volume":"66","author":"Ozpolat","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"7089","key":"10.1016\/j.nano.2022.102572_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nano.2022.102572_bb0020","article-title":"siRNA based drug design, quality, delivery and clinical translation","volume":"29","author":"Subhan","year":"2020","journal-title":"Nanomedicine"},{"issue":"31","key":"10.1016\/j.nano.2022.102572_bb0025","doi-asserted-by":"crossref","first-page":"16514","DOI":"10.1039\/D0NR02614J","article-title":"Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release","volume":"12","author":"Li","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2022.102572_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","article-title":"RNA Interference (RNAi)-based therapeutics: delivering on the promise?","volume":"56","author":"Bobbin","year":"2016","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.nano.2022.102572_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2085","article-title":"Illuminating the silence: understanding the structure and function of small RNAs","volume":"8","author":"Rana","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.nano.2022.102572_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.nano.2022.102572_bb0045","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI33494","article-title":"Nonviral delivery of synthetic siRNAs in vivo","volume":"117","author":"Akhtar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2022.102572_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2741\/4087","article-title":"siRNA delivery: from basics to therapeutic applications","volume":"18","author":"Musacchio","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"10.1016\/j.nano.2022.102572_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acscombsci.6b00073","article-title":"Cellular delivery of RNA nanoparticles","volume":"18","author":"Parlea","year":"2016","journal-title":"ACS Comb Sci"},{"issue":"12","key":"10.1016\/j.nano.2022.102572_bb0060","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/nprot.2011.418","article-title":"Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine","volume":"6","author":"Afonin","year":"2011","journal-title":"Nat Protoc"},{"issue":"27","key":"10.1016\/j.nano.2022.102572_bb0065","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.R900012200","article-title":"The RNA-induced silencing complex: a versatile gene-silencing machine","volume":"284","author":"Pratt","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2022.102572_bb0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2020.07.006","article-title":"Nanoparticle-siRNA: a potential strategy for rheumatoid arthritis therapy?","volume":"325","author":"Feng","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2022.102572_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4939-7138-1_16","article-title":"Oxime ether lipids as transfection agents: assembly and complexation with siRNA","volume":"1632","author":"Puri","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2760(95)00230-8","article-title":"The counterion influence on cationic lipid-mediated transfection of plasmid DNA","volume":"1299","author":"Aberle","year":"1996","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.nano.2022.102572_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0005-2736(97)00238-1","article-title":"Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA","volume":"1369","author":"Kariko","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/mp900298f","article-title":"The benefit of hydrophobic domain asymmetry on the efficacy of transfection as measured by in vivo imaging","volume":"7","author":"Nantz","year":"2010","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0095","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1039\/C9CP05405G","article-title":"Deciphering the response of asymmetry in the hydrophobic chains of novel cationic lipids towards biological function","volume":"22","author":"Mukherjee","year":"2020","journal-title":"Phys Chem Chem Phys"},{"issue":"1\u20132","key":"10.1016\/j.nano.2022.102572_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2012.04.017","article-title":"Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro","volume":"430","author":"Terp","year":"2012","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2022.102572_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.nano.2022.102572_bb0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.nano.2022.102572_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0076-6879(05)91001-X","article-title":"Entrapment of small molecules and nucleic acid-based drugs in liposomes","volume":"391","author":"Fenske","year":"2005","journal-title":"Methods Enzymol"},{"issue":"12","key":"10.1016\/j.nano.2022.102572_bb0120","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat Nanotechnol"},{"issue":"9","key":"10.1016\/j.nano.2022.102572_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nbt0918-777","article-title":"Alnylam launches era of RNAi drugs","volume":"36","author":"Garber","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.nano.2022.102572_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1358\/dot.2019.55.5.2958475","article-title":"Patisiran for the treatment of patients with familial amyloid polyneuropathy","volume":"55","author":"Rizk","year":"2019","journal-title":"Drug Today (Barcelona, Spain : 1998)"},{"key":"10.1016\/j.nano.2022.102572_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/d41586-020-03626-1","article-title":"The lightning-fast quest for COVID vaccines \u2014 and what it means for other diseases","volume":"589","author":"Ball","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nano.2022.102572_bb0140","article-title":"Covid-19: Pfizer-BioNTech vaccine is rolled out in US","volume":"371","author":"Tanne","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.nano.2022.102572_bb0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/14712598.2014.875524","article-title":"Novel RNA interference-based therapies for sepsis","volume":"14","author":"Kosovrasti","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2022.102572_bb0155","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1194\/jlr.M000513","article-title":"Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains","volume":"51","author":"Abate","year":"2010","journal-title":"J Lipid Res"},{"issue":"Pt A","key":"10.1016\/j.nano.2022.102572_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2022.102572_bb0165","first-page":"223","article-title":"Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet","volume":"7","author":"Gabizon","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0170","article-title":"Non-cationic material design for nucleic acid delivery","volume":"3","author":"Jiang","year":"2020","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.nano.2022.102572_bb0175","article-title":"Rationale and application of PEGylated lipid-based system for advanced target delivery of siRNA","volume":"11","author":"Ge","year":"2020","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.nano.2022.102572_bb0180","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"10.1016\/j.nano.2022.102572_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.nano.2022.102572_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2022.102572_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2016.03.006","article-title":"Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles","volume":"107","author":"Gonzalez-Fajardo","year":"2016","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.nano.2022.102572_bb0200","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbamem.2006.12.013","article-title":"Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding","volume":"1768","author":"Dos Santos","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2022.102572_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG - a versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.nano.2022.102572_bb0210","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat Mater"},{"issue":"9","key":"10.1016\/j.nano.2022.102572_bb0215","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol J"},{"issue":"1","key":"10.1016\/j.nano.2022.102572_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","article-title":"RNA interference-based therapy and its delivery systems","volume":"37","author":"Chen","year":"2018","journal-title":"Cancer Metastasis Rev"},{"issue":"18","key":"10.1016\/j.nano.2022.102572_bb0225","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2217\/nnm.15.105","article-title":"Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts","volume":"10","author":"Gupta","year":"2015","journal-title":"Nanomedicine (Lond)"},{"issue":"11","key":"10.1016\/j.nano.2022.102572_bb0230","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cmdc.201100259","article-title":"Hydrophobic oxime ethers: a versatile class of pDNA and siRNA transfection lipids","volume":"6","author":"Biswas","year":"2011","journal-title":"ChemMedChem"},{"issue":"13","key":"10.1016\/j.nano.2022.102572_bb0235","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.tetlet.2010.01.094","article-title":"Nucleophilic cationization reagents","volume":"51","author":"Biswas","year":"2010","journal-title":"Tetrahedron Lett"},{"issue":"4","key":"10.1016\/j.nano.2022.102572_bb0240","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-200060040-00006","article-title":"An updated review of its use in the management of adults with anxiety disorders","volume":"60","author":"Figgitt","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2022.102572_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-59745-191-8_1","article-title":"Principles of dicer substrate (D-siRNA) design and function","volume":"442","author":"Amarzguioui","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nano.2022.102572_bb0250","article-title":"Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells","volume":"26","author":"Puri","year":"2020","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.nano.2022.102572_bb0255","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.nano.2022.102572_bb0260","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.talanta.2005.08.031","article-title":"Analysis of liposomes","volume":"68","author":"Edwards","year":"2006","journal-title":"Talanta"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:17:52Z","timestamp":1761549472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":52,"alternative-id":["S1549963422000582"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102572","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102572"}}